Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - MusclePharm Corp | d937352dex321.htm |
| EX-31.1 - EX-31.1 - MusclePharm Corp | d937352dex311.htm |
| EX-10.1 - EX-10.1 - MusclePharm Corp | d937352dex101.htm |
| EX-10.4 - EX-10.4 - MusclePharm Corp | d937352dex104.htm |
| EX-31.2 - EX-31.2 - MusclePharm Corp | d937352dex312.htm |
| EX-10.6 - EX-10.6 - MusclePharm Corp | d937352dex106.htm |
| EX-10.5 - EX-10.5 - MusclePharm Corp | d937352dex105.htm |
| EX-10.2 - EX-10.2 - MusclePharm Corp | d937352dex102.htm |
| EX-10.3 - EX-10.3 - MusclePharm Corp | d937352dex103.htm |
| 10-Q - FORM 10-Q - MusclePharm Corp | d937352d10q.htm |
Exhibit 32.2
Section 1350 CERTIFICATION
In connection with this Quarterly Report of MusclePharm Corporation (the “Company”), on Form 10-Q for the quarter ended June 30, 2015, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, John Price, Principal Financial Officer of the Company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 10, 2015 | By: | /s/ John Price | ||||
| John Price | ||||||
| Principal Financial Officer |